FDA Inspection 1168808 — Regional Women's Health Group, LLC
The FDA completed an inspection of Regional Women's Health Group, LLC on Apr 22, 2022 in Marlton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 22, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Marlton, NJ (United States)